1. |
Supplemental ACIP advice for anthrax immunisation |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
2. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
3. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
4. |
Lipid-lowering therapy cost saving to prevent CV events in Italy |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 5-6
Laura Hunt,
Preview
|
|
摘要:
Cardiovascular (CV) diseases are a leading cause of mortality and morbidity worldwide, for which percutaneous transluminal coronary angioplasty (PTCA) and lipid-lowering therapy form part of the armamentarium for the primary prevention of CV disease events. At the 5th Annual European ISPOR*Congress [Rotterdam, The Netherlands; November 2002], three poster presentations revealed the costs and outcomes associated with atorvastatin and PTCA for the primary prevention of CV disease events, and those associated with amlodipine for use in patients undergoing PTCA. All three studies were conducted by an investigative team from the University of Milan, and Pfizer Italia, S.r.l, Italy; financial support for all three studies was provided by Pfizer Italia, S.r.l.
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
5. |
Patients may prefer rabeprazole over omeprazole |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
6. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
7. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
8. |
Extended-release ciprofloxacin a more convenient option for UTIs |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 9-10
Charles Bankhead,
Preview
|
|
摘要:
Urinary tract infection (UTI) is one of the most common complaints in clinical practice, particularly in the primary care setting. Results from a large, randomised controlled clinical trial presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) [San Diego, US; September 2002] showed that once-daily extended-release ciprofloxacin ['Cipro XR'] was at least as effective as conventional twice-daily ciprofloxacin ['Cipro'], but offered the convenience of a 3-day, 3-pill course of treatment.
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
9. |
Fasudil effective in stable angina pectoris |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
10. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1366,
2002,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|